Silent
Missense
Nonsense
Frequency of SNVs in pancancer level
| Cancer | Full Name | Mutation | Mutation Type | Sample Number |
|---|---|---|---|---|
| UCEC | Uterine Corpus Endometrial Carcinoma | A110T | Missense | 2 |
| UCEC | Uterine Corpus Endometrial Carcinoma | G99R | Missense | 2 |
| BLCA | Bladder urothelial carcinoma | F81F | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | F8L | Missense | 1 |
| BLCA | Bladder urothelial carcinoma | T189T | Silent | 1 |
| BLCA | Bladder urothelial carcinoma | V209V | Silent | 1 |
| BRCA | Breast invasive carcinoma | L338F | Missense | 1 |
| CESC | Cervical and endocervical cancers | C268Y | Missense | 1 |
| CESC | Cervical and endocervical cancers | F236L | Missense | 1 |
| CESC | Cervical and endocervical cancers | S424N | Missense | 1 |
| COAD | Colon adenocarcinoma | R106C | Missense | 1 |
| COAD | Colon adenocarcinoma | T390A | Missense | 1 |
| COAD | Colon adenocarcinoma | V280I | Missense | 1 |
| ESCA | Esophageal carcinoma | G226D | Missense | 1 |
| ESCA | Esophageal carcinoma | S312S | Silent | 1 |
| ESCA | Esophageal carcinoma | V292M | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | E140K | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | F144S | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | L385R | Missense | 1 |
| HNSC | Head and Neck squamous cell carcinoma | R163W | Missense | 1 |
| LAML | Acute Myeloid Leukemia | N148S | Missense | 1 |
| LGG | Brain Lower Grade Glioma | S272I | Missense | 1 |
| LIHC | Liver hepatocellular carcinoma | T189T | Silent | 1 |
| LUAD | Lung adenocarcinoma | I169L | Missense | 1 |
| LUAD | Lung adenocarcinoma | P23S | Missense | 1 |
| LUAD | Lung adenocarcinoma | Q52* | Nonsense | 1 |
| LUSC | Lung squamous cell carcinoma | E317* | Nonsense | 1 |
| OV | Ovarian serous cystadenocarcinoma | G176R | Missense | 1 |
| PRAD | Prostate adenocarcinoma | L158L | Silent | 1 |
| PRAD | Prostate adenocarcinoma | S351L | Missense | 1 |
| PRAD | Prostate adenocarcinoma | Y298S | Missense | 1 |
| SARC | Sarcoma | Y42C | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | F101S | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | L37M | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P222L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P373L | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | P98S | Missense | 1 |
| SKCM | Skin Cutaneous Melanoma | S63S | Silent | 1 |
| STAD | Stomach adenocarcinoma | A333V | Missense | 1 |
| STAD | Stomach adenocarcinoma | A382V | Missense | 1 |
| STAD | Stomach adenocarcinoma | A6T | Missense | 1 |
| STAD | Stomach adenocarcinoma | D379D | Silent | 1 |
| STAD | Stomach adenocarcinoma | D68N | Missense | 1 |
| STAD | Stomach adenocarcinoma | N220N | Silent | 1 |
| STAD | Stomach adenocarcinoma | R106H | Missense | 1 |
| STAD | Stomach adenocarcinoma | R60C | Missense | 1 |
| STAD | Stomach adenocarcinoma | V280I | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | D170D | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E330K | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | E347D | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | K44N | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | Q52R | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R215C | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | R305R | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | S74N | Missense | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | T250T | Silent | 1 |
| UCEC | Uterine Corpus Endometrial Carcinoma | V90I | Missense | 1 |
Mutational percentage of Silent, Missense and Nonsense for various cancers
Summary of mutation in pancancer level
| Cancer | Full Name | # Sample | % Silent | % Missense | % Nonsense |
|---|---|---|---|---|---|
| BLCA | Bladder urothelial carcinoma | 394 | 25 | 2.2 | 0 |
| BRCA | Breast invasive carcinoma | 976 | 0 | 2.2 | 0 |
| CESC | Cervical and endocervical cancers | 194 | 0 | 6.7 | 0 |
| COAD | Colon adenocarcinoma | 367 | 0 | 6.7 | 0 |
| ESCA | Esophageal carcinoma | 185 | 8.3 | 4.4 | 0 |
| GBM | Glioblastoma multiforme | 283 | 0 | 0 | 0 |
| HNSC | Head and Neck squamous cell carcinoma | 511 | 0 | 8.9 | 0 |
| KIRC | Kidney renal clear cell carcinoma | 476 | 0 | 0 | 0 |
| KIRP | Kidney renal papillary cell carcinoma | 282 | 0 | 0 | 0 |
| LAML | Acute Myeloid Leukemia | 192 | 0 | 2.2 | 0 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | 2.2 | 0 |
| LIHC | Liver hepatocellular carcinoma | 373 | 8.3 | 0 | 0 |
| LUAD | Lung adenocarcinoma | 533 | 0 | 4.4 | 50 |
| LUSC | Lung squamous cell carcinoma | 177 | 0 | 0 | 50 |
| OV | Ovarian serous cystadenocarcinoma | 465 | 0 | 2.2 | 0 |
| PAAD | Pancreatic adenocarcinoma | 126 | 0 | 0 | 0 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 0 | 0 | 0 |
| PRAD | Prostate adenocarcinoma | 498 | 8.3 | 4.4 | 0 |
| READ | Rectum adenocarcinoma | 122 | 0 | 0 | 0 |
| SARC | Sarcoma | 247 | 0 | 2.2 | 0 |
| SKCM | Skin Cutaneous Melanoma | 290 | 8.3 | 11.1 | 0 |
| STAD | Stomach adenocarcinoma | 393 | 16.7 | 15.6 | 0 |
| TGCT | Testicular Germ Cell Tumors | 147 | 0 | 0 | 0 |
| THCA | Thyroid carcinoma | 495 | 0 | 0 | 0 |
| THYM | Thymoma | 119 | 0 | 0 | 0 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 248 | 25 | 24.4 | 0 |